AI-generated summary
The authors tested a copper bromide plus yellow laser on Korean women with melasma, measuring clinical scores, skin color and tissue markers in biopsies from four patients. They report that the Melasma Area and Severity Index decreased after treatment and that markers of pigment, blood vessels and angiogenesis decreased. The authors suggest the laser may be a possible option for melasma with telangiectasia, but the sample was small.
- Who or what was studied
- Korean women with melasma; histopathologic analysis used punch biopsies from four patients
- Limits stated in the abstract
- The histopathologic analysis included only four patients, and the abstract presents the findings as a possible option rather than established efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 578 nm, 511 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.